Br J Haematol . Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors

[tetano]

Br J Haematol


. 2021 Oct 10.
doi: 10.1111/bjh.17864. Online ahead of print.
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors


Wei Yee Chan ^{1 2} , Lara Howells ¹ , William Wilson ³ , Emilie Sanchez ⁴ , Louise Ainley ^{1 2} , Selina J Chavda ^{1 2} , Emma Dowling ⁵ , Nuno Correia ⁵ , Catherine S Y Lecat ^{1 2} , Annabel McMillan ^{1 2} , Brendan Wisniowski ¹ , Shameem Mahmood ¹ , Xenofon Papanikolaou ¹ , Lydia Lee ^{1 2} , Jonathan Sive ¹ , Charalampia Kyriakou ¹ , Ashutosh Wechalekar ¹ , Rakesh Popat ¹ , Neil Rabin ¹ , Eleni Nastouli ⁴ , Kwee L Yong ^{1 2} , Ke Xu ¹



Affiliations

• PMID: 34632575
• DOI: 10.1111/bjh.17864

No abstract availableKeywords: humoral response; multiple myeloma; plasma cell disorders; severe acute respiratory syndrome coronavirus-2; vaccination response.